Literature DB >> 35818582

Age- and Gender-Related Differences in the Hemodynamic Status of Patients with Mild or Moderate Hypertension.

Marija Marjanovic1, Vesna Stojanov1,2, Ivan Marjanovic2,3, Gordana Vukcevic-Milosevic1, Nenad Radivojevic1, Dragan Matic1,2.   

Abstract

Purpose: The aim of this study was to use non-invasive impedance cardiography (ICG) to determine the hemodynamic status of patients with grade 1 and grade 2 hypertension in relation to gender and age. Patients and
Methods: We analyse prospectively collected data of 158 patients with grade 1 or grade 2 arterial hypertension. Patients were grouped according to age: 1) <50 years and 2) ≥50 years. Hemodynamic status of patients was assessed by using non-invasive ICG. For the purpose of this study two hemodynamic parameters were used: a) systemic vascular resistance index (SVRI) and b) left cardiac work index (LCWI). The primary endpoint was the hemodynamic status of patients. The secondary endpoint was hypertension-mediated organ damage.
Results: Increased SVRI was assessed in 80% of patients, more common in the ≥50 years group than in the <50 years group (88.5% vs 64.8%; p < 0.01). The occurrence of increased systemic vascular resistance correlates hierarchically with increasing age. Elevated LCWI (hypervolemia and/or hyperinotropy) was present in 63% of patients, more often in males than females (70.3% vs 57.1%; p < 0.05) as well in those <50 years than in older patients (70.4% vs 59.6%; p < 0.05). Patients with diabetes were less likely to have hypervolemia/hyperinotropy than those without diabetes (46.7% vs 67.2%; p < 0.01). Hypervolemia/hyperinotropy (46.7%) and hypovolemia/hypoinotropy (43.3%) were present in a similar percentage of diabetic patients. Left ventricular hypertrophy was found in 30 patients (19%). Patients with left ventricular hypertrophy were more commonly male (66.7% vs 42.2%; p = 0.016) and had increased systemic vascular resistance (96.7% vs 77.3%; p = 0.015) compared to the patients without left ventricular hypertrophy. Hypertensive retinopathy grade III was found in 14 patients (8.9%). Elevated daytime systolic pressure, diabetes and increased age are independent predictors of grade III hypertensive retinopathy. Patients with reduced renal function had higher mean systolic blood pressure (p < 0.05), were more commonly male (p < 0.01) and older (p < 0.01) than those without reduced renal function.
Conclusion: Although there are certain correlations between hemodynamic disorders and age and gender, specific hemodynamic status of an individual patient with hypertension cannot reliably be predicted on the basis of age and gender. The measurement of hemodynamic parameters by ICG can guide the clinician to select appropriate antihypertensive therapy to the patients' hemodynamic pathophysiologic condition.
© 2022 Marjanovic et al.

Entities:  

Keywords:  hemodynamics; hypertension; impedance cardiography

Year:  2022        PMID: 35818582      PMCID: PMC9270926          DOI: 10.2147/IJGM.S372092

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  18 in total

Review 1.  Hypertensive retinopathy.

Authors:  Tien Y Wong; Paul Mitchell
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

2.  2018 ESC/ESH Guidelines for the management of arterial hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 29.983

Review 3.  Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

4.  Some different types of essential hypertension: their course and prognosis.

Authors:  N M Keith; H P Wagener; N W Barker
Journal:  Am J Med Sci       Date:  1974-12       Impact factor: 2.378

5.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

Review 6.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

7.  Resistant hypertension: comparing hemodynamic management to specialist care.

Authors:  Sandra J Taler; Stephen C Textor; Jo Ellen Augustine
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

8.  Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials.

Authors:  Carlos M Ferrario; John M Flack; John E Strobeck; Gerard Smits; Celine Peters
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-12-30

9.  Hypertension management in England: a serial cross-sectional study from 1994 to 2011.

Authors:  Emanuela Falaschetti; Jennifer Mindell; Craig Knott; Neil Poulter
Journal:  Lancet       Date:  2014-05-31       Impact factor: 79.321

Review 10.  Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension.

Authors:  Giuliano Tocci; Enrico Agabiti Rosei; Ettore Ambrosioni; Claudio Borghi; Claudio Ferri; Andrea Ferrucci; Giuseppe Mancia; Alberto Morganti; Roberto Pontremoli; Bruno Trimarco; Alberto Zanchetti; Massimo Volpe
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.